Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
Breadcrumb Trail Links GlobeNewswire Author of the article: Published Feb 21, 2025 • 15 minute read Article content In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara …